Prices of US pharmaceuticals to rise by 25% due to tariffs hikes

Reuters reported on 25 Aprill that an anaysis, conducted by Ernst & Young, estimates that US drug costs could surge by nearly $51bn annually, translating to a potential price increase of up to 12.9% if these tariffs are passed on to consumers.

NHI uncertainty exposes cracks in medical scheme system

Against the backdrop of the State’s struggles to adequately finance existing social programmes, generating new funds for the NHI are more challenging. - Dr Anja Smith, senior researcher in the economics department at Stellenbosch University, and Claire Bisseker, an economics writer and researcher at the Bureau for Economic Research.

Immediate threats to private practice

On 8 April 2025 SAPPF members attended a webinar to discuss the immediate threats to private practice and in particular attempts to take control of the private sector and determine pricing as Government paves the way to implement the NHI.

‘Heart patch’ could help with transplant shortage

The journal Nature reported that German research discovered a potential solution – a “heart patch” made from stem cells that could provide a “bridge to transplantation, or maybe even a permanent fix.” MedicalBrief (24 April 2025)

[MORE]